Literature DB >> 20940232

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.

Alexandra Papaioannou1, Suzanne Morin, Angela M Cheung, Stephanie Atkinson, Jacques P Brown, Sidney Feldman, David A Hanley, Anthony Hodsman, Sophie A Jamal, Stephanie M Kaiser, Brent Kvern, Kerry Siminoski, William D Leslie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20940232      PMCID： PMC2988535          DOI： 10.1503/cmaj.100771

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  68 in total

Review 1.  Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials.

Authors:  Jennifer A Knopp; Barry M Diner; Maurice Blitz; George P Lyritis; Brian H Rowe
Journal:  Osteoporos Int       Date:  2004-12-22       Impact factor: 4.507

2.  The association between physical activity and osteoporotic fractures: a review of the evidence and implications for future research.

Authors:  Alireza Moayyeri
Journal:  Ann Epidemiol       Date:  2008-09-21       Impact factor: 3.797

3.  Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study.

Authors:  D L Schneider; E L Barrett-Connor; D J Morton
Journal:  JAMA       Date:  1997-02-19       Impact factor: 56.272

Review 4.  Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women.

Authors:  Anna M Sawka; Alexandra Papaioannou; Jonathan D Adachi; Amiram Gafni; David A Hanley; Lehana Thabane
Journal:  BMC Musculoskelet Disord       Date:  2005-07-11       Impact factor: 2.362

5.  Recommendations for bone mineral density reporting in Canada.

Authors:  Kerry Siminoski; William D Leslie; Heather Frame; Anthony Hodsman; Robert G Josse; Aliya Khan; Brian C Lentle; Jacques Lévesque; David J Lyons; Giuseppe Tarulli; Jacques P Brown
Journal:  Can Assoc Radiol J       Date:  2005-06       Impact factor: 2.248

6.  A meta-analysis of previous fracture and subsequent fracture risk.

Authors:  J A Kanis; O Johnell; C De Laet; H Johansson; A Oden; P Delmas; J Eisman; S Fujiwara; P Garnero; H Kroger; E V McCloskey; D Mellstrom; L J Melton; H Pols; J Reeve; A Silman; A Tenenhouse
Journal:  Bone       Date:  2004-08       Impact factor: 4.398

7.  Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: a clinical practice guideline from the American College of Physicians.

Authors:  Amir Qaseem; Vincenza Snow; Paul Shekelle; Robert Hopkins; Mary Ann Forciea; Douglas K Owens
Journal:  Ann Intern Med       Date:  2008-09-16       Impact factor: 25.391

8.  Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.

Authors:  Peter C Austin; Jack V Tu; Dennis T Ko; David A Alter
Journal:  CMAJ       Date:  2008-10-21       Impact factor: 8.262

Review 9.  Clinical decision support tools for osteoporosis disease management: a systematic review of randomized controlled trials.

Authors:  Monika Kastner; Sharon E Straus
Journal:  J Gen Intern Med       Date:  2008-10-04       Impact factor: 5.128

10.  Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast cancer.

Authors:  Georgiana K Ellis; Henry G Bone; Rowan Chlebowski; Devchand Paul; Silvana Spadafora; Judy Smith; Michelle Fan; Susie Jun
Journal:  J Clin Oncol       Date:  2008-08-25       Impact factor: 44.544
View more
  358 in total

1.  Atypical femur fractures: a survey of current practices in orthopedic surgery.

Authors:  P S Schneider; M Wall; J P Brown; A M Cheung; E J Harvey; S N Morin
Journal:  Osteoporos Int       Date:  2017-08-02       Impact factor: 4.507

2.  Individuals with neurological diseases are at increased risk of fractures within 180 days of admission to long-term care in Ontario.

Authors:  Micaela Jantzi; Amy C Maher; George Ioannidis; John P Hirdes; Lora M Giangregorio; Alexandra Papaioannou
Journal:  Age Ageing       Date:  2014-11-14       Impact factor: 10.668

3.  Quality-improvement interventions for osteoporosis: when are the results worth the effort?

Authors:  Sumit R Majumdar
Journal:  CMAJ       Date:  2012-01-09       Impact factor: 8.262

4.  Preventing fractures in postmenopausal women: how to assess risk.

Authors:  Vincent Fung; David Kendler
Journal:  CMAJ       Date:  2011-10-31       Impact factor: 8.262

5.  Arthritis, osteoporosis, and low back pain: evidence-based clinical risk assessment for physical activity and exercise clearance.

Authors:  Jamie Burr; Roy Shephard; Stephen Cornish; Hassanali Vatanparast; Philip Chilibeck
Journal:  Can Fam Physician       Date:  2012-01       Impact factor: 3.275

Review 6.  Annual adult health checkup: update on the Preventive Care Checklist Form(©).

Authors:  Anthony Duerksen; Vinita Dubey; Karl Iglar
Journal:  Can Fam Physician       Date:  2012-01       Impact factor: 3.275

7.  Nutrition: calcium and vitamin D for extraskeletal health--jury is out.

Authors:  Soledad Velasco; Sophie A Jamal
Journal:  Nat Rev Endocrinol       Date:  2012-01-31       Impact factor: 43.330

8.  Too Fit To Fracture: exercise recommendations for individuals with osteoporosis or osteoporotic vertebral fracture.

Authors:  L M Giangregorio; A Papaioannou; N J Macintyre; M C Ashe; A Heinonen; K Shipp; J Wark; S McGill; H Keller; R Jain; J Laprade; A M Cheung
Journal:  Osteoporos Int       Date:  2013-11-27       Impact factor: 4.507

9.  Comparative gastrointestinal safety of bisphosphonates in primary osteoporosis: a network meta-analysis.

Authors:  M Tadrous; L Wong; M M Mamdani; D N Juurlink; M D Krahn; L E Lévesque; S M Cadarette
Journal:  Osteoporos Int       Date:  2013-11-28       Impact factor: 4.507

10.  Prevalence of osteoporosis in men aged 65-75 in a primary care setting. A practice audit after application of the Canadian 2010 guidelines for osteoporosis screening.

Authors:  Robert Ferrari
Journal:  Clin Rheumatol       Date:  2014-04-30       Impact factor: 2.980
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.